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Abstract
There exists little to no data on the development of donor-site scars that remain after
split skin graft harvesting. The objectives of this study were to (a) examine changes in
characteristics of donor-site scar quality over time and (b) assess the agreement
between patient-reported and observer-reported donor-site scar quality in a burn
population. A prospective cohort study was conducted including patients who under-
went split skin grafting for their burn injury. Patients and observers completed the
Patient and Observer Scar Assessment Scale (POSAS) for the first harvested donor
site at 3 and 12 months post-surgery. This study included 80 patients with a median
age of 34 years. At 3 months post-surgery, the patients scored the POSAS items itch
and color as most deviant from normal skin, both improved between 3 and
12 months (3.1 vs 1.5 and 5.0 vs 3.5, respectively [P < .001]). Other scar characteris-
tics did not show significant change over time. The patients' overall opinion score
improved from 3.9 to 3.2 (P < .001). Observers rated the items vascularization and
pigmentation most severe, only vascularization improved significantly between both
time points. Their overall opinion score decreased from 2.7 to 2.3 (P < .001). The
inter-observer agreement between patients and observers was considered poor
(ICC < 0.4) at both time points. Results of current study indicate that observers
underestimate the impact of donor-site scars. This has to be kept in mind while guid-
ing therapy and expectations.
LEVEL OF EVIDENCE: II, prospective cohort study.
1 | BACKGROUND
Split skin grafting remains a widely used reconstructive technique for
chronic wounds, burns, and other traumatic wounds. The procedure
involves harvesting of the full epidermis and part of the dermis, cre-
ating a secondary wound at the donor site. Because skin grafting is
necessary to cover the wound, scars of these donor sites might be
considered as subservient. Unlike for other wounds, there is little to
no data on the development of donor-site wounds and their final
appearance, even though the donor site can be a considerable bur-
den to patients during and after the healing process.1,2
Integrating scar evaluations of patients in clinical assessments is pro-
moted based on findings that patient-rated scar severity is directly related
to psychological distress, whereas observer-rated scar severity is unrelated
to psychological distress.3 Assessment of scars by both patients' and pro-
fessionals' provides more useful information regarding the patients' well-
being compared to focusing on the separate assessments only.4
Eskes et al investigated patients' and observers' judgments and
satisfaction with respect to donor-site scars at 3 months after wound
Abbreviations: POSAS, Patient and Observer Scar Assessment Scale; TBSA, total body
surface area.
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healing.5 They found discrepancies between patients' and observers'
opinions on different characteristics of donor-site scars.5 However,
they included mainly male patients who underwent surgery in a
nonacute setting and only included adults with a mean age of
59.6 years.6 Furthermore, scars were assessed at 12 weeks post-sur-
gery, which limits the insight into the final situation of the scar as the
active transformation processes and maturation of scars takes at least
1 year.7-9
The objectives of this study were to (a) examine changes in char-
acteristics of donor-site scar quality over time and get insight into
final scar appearance at 12 months post-surgery and (b) to assess the
extent of agreement between patients' ratings and observers' rating
of donor-site scar characteristics in a burn population. The ultimate
aim of the current study was to improve information given to patients
and eventually ensure high-quality patient-centered care.
2 | PATIENTS AND METHODS
2.1 | Study design and patients
An observational prospective cohort study was performed. From
February 2016 to February 2017, patients were included in the burn
center of the Maasstad Hospital in Rotterdam, the Netherlands.
Patients of all ages who underwent split skin grafting for an acute
burn were eligible to participate. Patients were excluded if they had
cognitive impairments or were unable to understand or answer ques-
tionnaires in Dutch or English. Written informed consent was
obtained from each patient and patients received standard treatment.
Strengthening the Reporting of Observational Studies in Epidemiology
(STROBE) guidelines were adhered to in this study and manuscript.
The study was approved by the regional Medical Ethics Committee
(reference number L2016119) and conducted according to the princi-
ples of the Declaration of Helsinki. Scar quality of the first harvested
donor site was evaluated at 3 and 12 months post-surgery during rou-
tine outpatient visits. Other study parameters were documented dur-
ing admission, surgery, and outpatient visits. These were patient
characteristics: age at surgery, gender, and skin type. Registered clini-
cal characteristics were burn-related: % total burned body surface
area (TBSA), % TBSA excised, length of stay, and donor site-related:
location on the body, >2 weeks to re-epithelization, and wound
infection.
2.2 | Treatment
Patients received standard treatment peri-operatively. Split-thickness
skin grafts were harvested at a depth of 0.2 mm (0.007 in.) with an
electric dermatome. Adrenaline soaked alginate dressings were place
on the wounds immediately after grafting to reduce blood loss.
Afterward, donor-site wounds were covered with an alginate dressing,
cotton wool and elastic bandages, which were removed 2 weeks post-
surgery.
2.3 | Scar outcome
The Patient and Observer Scar Assessment Scale (POSAS) version 2.0
was used to assess scar quality.10 The POSAS is a validated measure-
ment scale for scar quality of burn and linear scars and therefore
seemed most suitable to assess scar quality of donor sites.10-13 The
POSAS consists of a patient and observer (ie, caregiver) part. Both
patient and observers rated the same scar on six different scar charac-
teristics, with roughly an overlap of four characteristics (Table 2). This
enabled the identification of differences between patients and
observers and specific scar characteristics that may be more trouble-
some than others from the patients' point of view.
The patient part involves the scar characteristics pain, itch,
color (a combination of vascularization and pigmentation), thick-
ness, relief (surface roughness), and pliability (stiffness). The param-
eters pain and itch measure the extent to which the donor-site
scars have been painful or itching over the past few weeks. The
parameters color, thickness, and pliability describe the patients'
judgment of whether the color, thickness, and stiffness of the
donor-site scar differed from the normal skin. The parameter relief,
which includes the surface roughness of the donor-site scar area,
described the presence of surface irregularities. The observer scale
includes vascularization, pigmentation, thickness, surface, relief,
and pliability. Each of the six scar characteristics was rated on a
10-point scale, which ranges from 1 (comparable to normal skin) to
10 (very different from normal skin).
In addition, patients and observers complete 1 item to measure
their overall opinion on the donor-site scar, ranging from 1 (best scar
imaginable) to 10 (worst scar imaginable).
2.4 | Statistical analysis
2.4.1 | Characteristics
Descriptive statistics were used to present data on patient charac-
teristics (age, sex, and Fitzpatrick skin type), clinical characteristics
(cause of the burn, percentage total body surface area [TBSA] bur-
ned, percentage TBSA excised, and length of stay), and donor-site
characteristics (anatomical location of the donor site, >2 weeks to
re-epithelization, infection).
2.4.2 | Changes of scar quality over time
The Wilcoxon signed-rank test was used to analyze differences per
POSAS item between 3 and 12 months. A P-value <.05 was consid-
ered significant. Additionally, the effect size was calculated by dividing
the Z-value by the square root of number of cases. An effect size
above 0.5 was considered as a “large effect,” between 0.3 and 0.5 as a
“moderate effect” and between 0.1 and 0.3 as a “small effect” and
beneath 0.1 “trivial.” In other words, the larger the effect size, the
greater the change in scar quality.14
2 LEGEMATE ET AL.
2.4.3 | Agreement between patients and observers
The agreement between patients and observers on the POSAS items
was assessed in three ways. First, the inter-observer reliability (IOR)
was used to determine the agreement between the patient-ratings
and observer-ratings regarding the different items on quality of the
donor-site scars. The IOR was expressed as intra-class correlation
coefficient (ICC) for the POSAS items, including their 95% confidence
intervals (CI), and calculated using a two-way mixed random effect
model for single measures consistency.15,16 The ICC was calculated
for the corresponding items (color, vascularity, pigmentation, relief,
and thickness) and overall opinion item. To be able to compare the
color assessments of the patients with the color assessments of the
professionals, an average score for the items vascularity and pigmen-
tation was calculated. ICC values range from no agreement (0) to per-
fect agreement (1).17,18 ICC values beneath 0.4 are considered as
“poor agreement,” between 0.4 and 0.6 as “moderate agreement,”
between 0.6 and 0.8 as “good agreement” and above 0.8 as “very
good agreement”.17,18 Second, the 95% limits of agreement approach
(Bland and Altman plots) were used to assess the score agreement
between the patients' and observers' judgment of the overall opin-
ion.19,20 Third, a sub analysis on the corresponding POSAS items was
performed to analyze whether the patients judged their scars more
severe, identical or less severe compared to the observers. All data ana-
lyses were performed using statistical software (IBM, SPSS, V.24.0).
3 | RESULTS
Out of 113 eligible patients, 80 patients were included in the study.
Participants had a median age of 34 (range 0-84) and most were male
(65.0%). Median percentage TBSA burned was 6.0 (range 0.5-55) and
most donor sites were placed on the thigh (73.8%) (Table 1). During
3-month follow-up, 73 patients (91%) completed the POSAS. During
12-month follow-up, 72 patients (90%) completed the POSAS
(Figure 1). A nonresponse analysis showed no differences in age, gen-
der, and %TBSA burned.
3.1.1. | Scar quality and changes over time
At 3 months post-surgery, the patients rated the scar characteristics
color and itch most severe (Figure 2). The mean scores for color and
itch significantly decreased (eg, improved) between 3 and 12 months
(3.1 vs 1.5 and 5.0 vs 3.5, respectively, both P < .001) with an effect
size of 0.53 and 0.48, indicating a moderate effect. No significant
change was seen for the other items (Figure 2, Supplementary Digital
Content S1), but the mean overall opinion of the patients significantly
decreased from 3.9 to 3.2 (effect size 0.49, P < .001).
The observers rated the characteristics vascularization and pig-
mentation most severe at 3 months post-surgery (3.3 and 2.5, respec-
tively) (Figure 2, Supplementary Digital Content S1). The mean item
scores of vascularization and pliability decreased significantly with an
effect-size of 0.84 (large effect, P < .001) and 0.2 (small effect,
P < .05), respectively. The mean overall opinion of the observers sig-
nificantly decreased from 2.7 to 2.3 (effect size 0.46, P < .001).
3.1.2. | Agreement between patients and observers
Table 2 shows the agreement in terms of inter-observer agreement
between patients and observers on the corresponding POSAS items.
The agreement on the items pliability, thickness, and relief increased
between 3 and 12 months. Agreement on POSAS items was all poor;
however, at 12 months, at best for the item color/pigmentation (0.38,
95% CI: 0.16-0.56).
The limits of agreement approach showed that 95% of the patient
overall opinion item differed up to 4.74 points from the observers
with a systematic difference of 1.05 at 3 months and 0.89 at
12 months, indicating a slightly better agreement between the asses-
sors at 12 months. Both plots visualize that the difference between
the patients and observers tends to get larger as the average overall
opinion score increases (ie, if the overall opinion gets worse)
(Figure 3).
Figure 4 presents the agreement in terms of the proportion of
patients that score their scar more severe, identical or less severe
compared to the observer. Patient and observer scar assessment
scores of the items relief and pliability were identical in more than
50% of the cases, whereas the agreement on color (vascularity and
pigmentation) was below 20% at both time points. Overall, patients
rated the scar characteristic color (pigmentation and vascularization)
TABLE 1 Baseline characteristics
Demographics Total population (n = 80)
Age, median (range) 34 (0-84)
Male, n (%) 52 (65.0)
Skin type [FP >3], n (%) 21 (26.4)
Clinical characteristics
Cause of the burn
Scald (%) 19 (23.8)
Flame/fire (%) 39 (48.8)
Hot fat (%) 4 (5.0)
Other (%) 18 (22.5)
%TBSA burned, median (range) 6 (0.5-55)
%TBSA excised, median (range) 2 (0.5-50)
LOS in days, median (range) 16 (0-94)
Donor-site characteristics
Location of the donor-site
Thigh (%) 59 (73.8)
Other (%) 21 (26.4)
Time to re-epithelization (>2 weeks), n(%) 58 (74.4)
Wound infection, n(%) 7 (8.8)
Abbreviation: TBSA, total burned body surface area.
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and their overall opinion on the scar more severe than observers.
If patients rated their scar less severe than observers, the mean
difference was less than one point for all items (Supplementary Digi-
tal Content S2). If patients rated the scar more severe than
observers, the mean difference was more than two points for all
items (Supplementary Digital Content S2).
4 | DISCUSSION
To our knowledge, this is the first study that investigated patient- and
observer-reported scar quality of donor sites up to 1 year post-sur-
gery. Patients' and observers' perceptions of scar quality only slightly
improved during scar maturation. The agreement between patients
F IGURE 1 Inclusion flowchart
F IGURE 2 Patients and Observers (ie, caregivers) Scar Quality scores at 3 and 12 months post-surgery. Bars represent the mean item score
and SD. A lower Patient and Observer Scar Assessment Scale (POSAS) score correlates with a better scar; a score of 10 reflects the worst
imaginable scar. A score of 1 means no difference from normal skin. *P < .001, **P < .05 (Wilcoxon signed-rank test)
4 LEGEMATE ET AL.
and observers generally increased between 3 and 12 months but
remained “poor” for all items of the POSAS. Results of this study indi-
cate that caregivers seem to underestimate the impact of scars on
patients. Especially the items on color were rated more severe by
patients.
The magnitude of the observed improvement in scar quality
over time was limited in our study population. Patient satisfaction
regarding donor sites may improve over time as a result of scar
maturation but may on the other hand deteriorate as a result of
psychological sequelae, especially when the recipient site is
completely healed and the patient might have expected that the
donor-site scar would fade. The small changes over time that we
observed in the perception of scar quality and satisfaction are
consistent with previous studies on other scar types.7,9 Our
results show that items on color (color on the patients scale, vas-
cularization, and pigmentation on the observer scale) are rated
the worst out of all items by both patients and observers at both
time-points. Patients rated color less severe at 12 months post-
surgery while observers only rated the item vascularization less
severe at 12 months post-surgery. This might indicate that the
appreciation of the item “color” grows as a result of the reduction
of erythema and that pigment changes contribute less to the
improvement. This is in line with one study that measured ery-
thema and melanin indexes of donor site scars with an objective
measurement instrument in patients with chronic leg ulcers.2 That
study found that the erythema index decreased 109% from 3 to
12 months post-surgery, while pigmentation only decreased 24%
compared to normal skin. Studies that investigated patient- and
observer-reported scar quality of burn wounds also found that
items on color were rated worse than other items.7,21 The severe
scores and reduction over time that we found for patient-
reported itching are also in accordance with previous studies
regarding burn and linear scars.7,12,13
The items pliability, thickness, and relief seem of less importance
in our study population than to populations with burn scars or linear
scars.7,12,13 Nevertheless, it is of note that none of the POSAS items
had a mean score of 1 (ie, the same as normal skin) at 12 months
post-surgery.
Patients and observers showed only poor-to-moderate agree-
ment on scar quality at both time points. For the overall opinion on
the scar, agreement was poor as well. Patients especially scored
color worse than observers, while observers seemed to underline
the importance of thickness. This might be due to the fact that
hypertrophy of donor-site scars is not expected by the observers
and may be seen as pathological scarring, while patients might
compare the donor-site scar to their burn scar and consequently
downgrade hypertrophy. The limited agreement on specific items
that we found between patients and observers is consistent with
studies that reported differences in scar appreciation between
patients and observers on linear scars.5,22-24 Eskes et al only found
a “moderate” agreement on the overall opinion item of the POSAS
on donor-site scars in a general trauma population and also a
F IGURE 3 Bland and Altman plots demonstrating the agreement of Patient and Observer Scar Assessment Scale (POSAS) overall opinion
scores between patients and caregivers at 3 (left) and 12 (right) months post-surgery. Each dot in the figure represents a donor-site scar judged
by the patient and observers. The difference between the two ratings is on the Y-axis and the average of both ratings on the X-axis. The dotted
lines represent the 95% confidence intervals (limits of agreement −2.63 to 4.74 and −2.95 to 4.74) and the black line the mean difference
between the raters (mean difference 1.055 and 0.892)
TABLE 2 Inter-observer reliability between patients and
caregivers
POSAS items 3 months ICC (95% CI) 12 months ICC (95% CI)
Color/vascularity 0.29 (0.07 to 0.49) 0.14 (−0.09 to0.36)
Color/pigmentation 0.05 (0.28 to 1.11) 0.38 (0.16 to 0.56)
Color/combinationa 0.08 (0.30 to 1.17) 0.20 (−0.03 to 0.41)
Pliability 0.30 (0.08 to 0.50) 0.31 (0.09 to 0.54)
Thickness 0.19 (−0.05 to 0.40) 0.36 (0.15 to 0.55)
Relief 0.23 (−0.01 to 0.44) 0.36 (0.14 to 0.54)
Overall opinion 0.20 (−0.02 to 0.41) 0.24 (0.02 to 0.45)
Note: ICC values range from no agreement (0) to perfect agreement
(1).17,18 ICC values beneath 0.4 are considered as “poor agreement,”
between 0.4 and 0.6 as “moderate agreement,” between 0.6 and 0.8 as
“good agreement” and above 0.8 as “very good agreement.”17,18
Abbreviation: ICC, intra-class correlation coefficient; POSAS: Patient and
Observer Scar Assessment Scale.
aCombination: Average score of vascularity and pigmentation.
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“poor” agreement for all other items. However, they did not study
the magnitude or direction of the differences between patients'
and observers'.5 Hoogewerf et al studied the magnitude and direc-
tion of differences in assessment of facial burn scars for patients
and observers in a Dutch burn population.4 They found that 53%
of the patients' and observers' assessments were identical. In our
study population, this was only 24% and 37%, at, respectively,
3 and 12 months. In other words, there seems to be a worse agree-
ment in the judgment of donor-site scars compared to the
recipient site.
Surgeons should be aware of the fact that patients might have
different views on scar outcomes after split skin grafting. Patients
are often well informed on the (development of ) scars at the
recipient site, but just have to deal with the emergence of a
donor-site scar. Our results can be used to manage patients'
expectations regarding donor-site scar quality after split skin
grafting. Effective communication can improve patient satisfac-
tion and outcome. However, it is difficult to predict psychological
distress based on the severity of disfigurement. Therefore, future
studies should investigate the relationship between donor-site
scar quality and psychological distress or quality of life.25 Results
of our study can also be used as a starting point for scar quality
improvement. Concerns about donor-site scarring may be more
significant than surgeons might expect; the mean overall opinion
of the patient on the donor-site scar was still 3.2 after 1 year
(in comparison: two large cohort studies found that patients
scored the overall opinion on their burn scar 4.1, at 1 - ≥5 years
post burn7,21). Many studies have been performed on donor-site
management ranging from different types of wound dressings to
more innovative (surgical) techniques, including harvesting of the
skin from a different location (ie, buttock or skull) or the use of
other harvesting methods, like dermal grafting.26-29 Caregivers
should be aware of these options, which may increase scar quality.
However, most studies on the outcomes of these treatment
options focus on early and rapid re-epithelialization but lack data
on patient reported (long term) scar appearance.26 Further
research is, therefore, necessary to investigate which patients
benefit from these techniques.
This study has limitations that should be noted. The POSAS
was used to assess scar quality. Although this is the only scar
assessment scale that takes the opinion of the patient into account
and has been validated for judgment of burn and linear scars, there
has never been a reference or golden standard with regard to the
quality of scars. In our study, this is of less importance because
the patients' perception is the ultimate outcome to come to the
best patient-centered care. Nevertheless, a minimal important
change analysis is never done for the POSAS and it is therefore
unknown if patients or observers judged the observed changes
between 3 and 12 months important or meaningful. Another limi-
tation is that this study is part of an explorative cohort study
wherefore it was decided a priori to include patients over a 1-year
period. The accuracy of the agreement might be limited as illus-
trated by the wide confidence intervals and might be due to an
insufficient sample size. However, the agreement between items
was “poor” at best. So even if the number of included patients
would decrease confidence limits, this will probably not lead to a
“good” agreement.
5 | CONCLUSION
The agreement on donor-site scar quality between patients and
observers is limited. Surgeons should be aware that patients might
have a different view on donor-site scars. This realization is important
to manage patient expectations regarding scar quality after split skin
grafting and pre-surgical counseling of patients with regard to
F IGURE 4 The agreement in terms of the proportion of patients that score their scar quality more severe, identical or less severe compared
to the observer
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anticipated anxiety about scar appearance and quality improvement.
Effective communication may improve patient satisfaction.
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